Charming Medical Limited Class A Ordinary Shares MCTA · SEC Filings

website

Operating through its subsidiaries and under the Beauty Lab brand in Hong Kong, Charming Medical Lim...

Price29.355

Market Cap445.63 M

Float4.83 M

CountryHK

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

Financials

TYPE

HEADLINE

FILED AT

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Jul 30, 2026

News

TYPE

HEADLINE

FILED AT

6-K

NEWCharming Medical Limited Announces Nasdaq Delisting Determination and Suspension of Trading

Nov 9, 2026

6-K

Charming Medical Limited Receives Nasdaq Delisting Determination Notice

Nov 5, 2026

6-K

Notice of Extraordinary General Meeting for Charming Medical Limited to Approve Cancellation of Class B Shares and Removal of Dual-Class Structure

Sep 29, 2026

6-K

Charming Medical Limited Announces Corporate Governance Enhancements and Abolition of Dual-Class Share Structure

Jul 21, 2026

6-K

Charming Medical Limited Announces Board of Directors Changes

May 6, 2026

6-K

Charming Medical Limited Appoints Matthew Mo Kan Tsui as Independent Director

Apr 2, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B4

SHARE RESALE REGISTRATION | Shares amount: 1,600,000 | Share price: $4 |

Oct 21, 2025

Registrations

TYPE

HEADLINE

FILED AT

8-A12B

Form 8-A12B - Registration of securities [Section 12(b)]

Oct 20, 2025

F-1/A

SHARE RESALE REGISTRATION

Sep 10, 2025

FWP

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses

Aug 7, 2025

F-1/A

SHARE RESALE REGISTRATION | Shares amount: 1,600,000 | Share price: $5

Jul 30, 2025

FWP

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses

Jun 3, 2025

F-1/A

SHARE RESALE REGISTRATION | Shares amount: 1,600,000 | Share price: $5

May 27, 2025

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

SCHEDULE 13D

Wong Kit Christine (Filed by)

Mar 27, 2026

YU SHU TAI VICTOR (Reporting)

Mar 27, 2026

Wong Kit Christine (Reporting)

Mar 27, 2026

CHEUNG CHING MAN (Reporting)

Mar 27, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Oct 1, 2025

CORRESP

Form CORRESP - Correspondence

Sep 29, 2025

CORRESP

Form CORRESP - Correspondence

Sep 29, 2025

CORRESP

Form CORRESP - Correspondence

May 27, 2025

LETTER

Form UPLOAD - SEC-generated letter

May 19, 2025

LETTER

Form UPLOAD - SEC-generated letter

Mar 25, 2025